---
figid: PMC3265821__sgtp0205_0289_fig001
figtitle: Change in RAF isoform usage in response to a RAS mutation
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC3265821
filename: sgtp0205_0289_fig001.jpg
figlink: /pmc/articles/PMC3265821/figure/F1/
number: F1
caption: 'Change in RAF isoform usage in response to a RAS mutation. In melanocytes,
  activation of cAMP not only stimulates melanogenesis but also inhibits the kinase
  CRAF. Therefore, BRAF activates the MAPK pathway downstream of RTKs in these cells.
  In melanomas containing a mutation of RAS, BRAF kinase is phosphorylated by ERK
  inhibiting its interaction with RAS. Hence, it is CRAF that activates the MAPK pathway
  downstream of RAS. Overexpression of PDE4 degrades cAMP preventing inhibition of
  CRAF by PKA. α-MSH: melanocyte stimulating hormone; MC1R: melanocortin-1 receptor,
  AC: adenylyl cyclase, PDE: phosphodiesterase, PKA: protein kinase A, CREB: cAMP
  responsive element binding protein, MITF: microphtalmia associated transcription
  factor; GF: growth factor; RTK: receptor tyrosine kinase.'
papertitle: Mechanism of RAF isoform switching induced by oncogenic RAS in melanoma.
reftext: Nicolas Dumaz. Small GTPases. 2011 Sep-Oct;2(5):289-292.
year: '2011'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.6620576
figid_alias: PMC3265821__F1
figtype: Figure
redirect_from: /figures/PMC3265821__F1
ndex: c9ed7fd8-df34-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3265821__sgtp0205_0289_fig001.html
  '@type': Dataset
  description: 'Change in RAF isoform usage in response to a RAS mutation. In melanocytes,
    activation of cAMP not only stimulates melanogenesis but also inhibits the kinase
    CRAF. Therefore, BRAF activates the MAPK pathway downstream of RTKs in these cells.
    In melanomas containing a mutation of RAS, BRAF kinase is phosphorylated by ERK
    inhibiting its interaction with RAS. Hence, it is CRAF that activates the MAPK
    pathway downstream of RAS. Overexpression of PDE4 degrades cAMP preventing inhibition
    of CRAF by PKA. α-MSH: melanocyte stimulating hormone; MC1R: melanocortin-1 receptor,
    AC: adenylyl cyclase, PDE: phosphodiesterase, PKA: protein kinase A, CREB: cAMP
    responsive element binding protein, MITF: microphtalmia associated transcription
    factor; GF: growth factor; RTK: receptor tyrosine kinase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CG2224
  - Dr
  - Sos
  - drk
  - ac
  - ras
  - Ras64B
  - Ras85D
  - ATPsynbeta
  - Atpalpha
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - dnc
  - Dsor1
  - Mtk
  - CrebB
  - CrebA
  - Erk7
  - rl
  - rr
  - Mitf
  - STAMBP
  - MSX2
  - POMC
  - XYLT2
  - SOS1
  - SOS2
  - GRB2
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - KRAS
  - HRAS
  - NRAS
  - ATP8A2
  - BRAF
  - RAF1
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - ALDH7A1
  - PDE2A
  - PDE9A
  - PDE10A
  - PDE11A
  - PDE1A
  - PDE1B
  - PDE1C
  - PDE3A
  - PDE3B
  - PDE4A
  - PDE4B
  - PDE4C
  - PDE4D
  - PDE6A
  - PDE6B
  - PDE6C
  - PDE7A
  - PDE7B
  - PDE8A
  - PDE8B
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - EPHB2
  - MAPK1
  - MAPK3
  - MITF
  - Cardiomyopathy
  - Noonan syndrome
---
